2024-01-29 23:17:04 ET
Summary
- From 2006-2023, The Crossing Wall Street's "Buy List" beat the S&P 500 Index by 130%. In 2016, CWS launched, allowing investors the chance to benefit from the simple 25-stock ETF.
- But there are two catches. The first is how much CWS's 0.84% expense ratio diminishes returns. The second is how most of this outperformance was isolated to a single year.
- It's reasonable to question whether Eddy Elfenbein, Crossing Wall Street's founder, can generate alpha moving forward. Since the ETF's launch, it's lagged SPY by 0.73% per year.
- Unfortunately, I also don't find the current portfolio compelling. While it is low-beta, weak profitability metrics and an unattractive growth/value combination lead me to limit my rating to a hold.
Investment Thesis
Read the full article on Seeking Alpha
For further details see:
CWS: Can Crossing Wall Street's Founder Guide You To 130% Gains Over SPY?